| scholarly article | Q13442814 |
| P50 | author | Wafik El-Deiry | Q4118647 |
| P2093 | author name string | Jing Xu | |
| Wenge Wang | |||
| Gen Sheng Wu | |||
| David T Dicker | |||
| Kageaki Kuribayashi | |||
| Patrick A Mayes | |||
| Gabriel Krigsfeld | |||
| P433 | issue | 12 | |
| P304 | page(s) | 2034-2038 | |
| P577 | publication date | 2008-12-01 | |
| P1433 | published in | Cancer Biology and Therapy | Q2544651 |
| P1476 | title | TNFSF10 (TRAIL), a p53 target gene that mediates p53-dependent cell death | |
| P478 | volume | 7 |
| Q36685480 | 5-Fluorouracil-induced RNA stress engages a TRAIL-DISC-dependent apoptosis axis facilitated by p53. |
| Q41958588 | Alveolar epithelial cells in idiopathic pulmonary fibrosis display upregulation of TRAIL, DR4 and DR5 expression with simultaneous preferential over-expression of pro-apoptotic marker p53. |
| Q57461774 | C/EBPβ deletion in oncogenic Ras skin tumors is a synthetic lethal event |
| Q94527342 | Cisplatin sensitivity mediated by NKX2-1 in lung adenocarcinoma is dependent on p53 mutational status via modulating TNFSF10 expression |
| Q34490533 | Complex changes in the apoptotic and cell differentiation programs during initiation of the hair follicle response to chemotherapy |
| Q53701901 | Developing TRAIL/TRAIL death receptor-based cancer therapies. |
| Q34359953 | Diet and lifestyle factors modify immune/inflammation response genes to alter breast cancer risk and prognosis: the Breast Cancer Health Disparities Study |
| Q35951059 | Dual inactivation of Akt and ERK by TIC10 signals Foxo3a nuclear translocation, TRAIL gene induction, and potent antitumor effects |
| Q35625337 | FCRL5 Delineates Functionally Impaired Memory B Cells Associated with Plasmodium falciparum Exposure |
| Q35844988 | First-In-Class Small Molecule ONC201 Induces DR5 and Cell Death in Tumor but Not Normal Cells to Provide a Wide Therapeutic Index as an Anti-Cancer Agent |
| Q39707551 | Functional implication of TRAIL -716 C/T promoter polymorphism on its in vitro and in vivo expression and the susceptibility to sporadic breast tumor |
| Q92461964 | Gene Expression of Molecules Regulating Apoptotic Pathways in Glioblastoma Multiforme Treated with Umbilical Cord Stem Cell Conditioned Medium |
| Q35974121 | Genetic Evaluation of Schizophrenia Using the Illumina HumanExome Chip |
| Q33835336 | Gga-miR-219b targeting BCL11B suppresses proliferation, migration and invasion of Marek's disease tumor cell MSB1 |
| Q35844979 | Gonadal Transcriptome Analysis in Sterile Double Haploid Japanese Flounder |
| Q35595688 | Identification of TRAIL-inducing compounds highlights small molecule ONC201/TIC10 as a unique anti-cancer agent that activates the TRAIL pathway |
| Q64077766 | Impact of p53 status on TRAIL-mediated apoptotic and non-apoptotic signaling in cancer cells |
| Q34419090 | Investigation of DNA damage response and apoptotic gene methylation pattern in sporadic breast tumors using high throughput quantitative DNA methylation analysis technology. |
| Q41396848 | Milk disrupts p53 and DNMT1, the guardians of the genome: implications for acne vulgaris and prostate cancer |
| Q50933551 | Overexpression of BCLXL in Osteoblasts Inhibits Osteoblast Apoptosis and Increases Bone Volume and Strength. |
| Q58377942 | P53 and Cell Death |
| Q38994024 | PRIMA-1, a mutant p53 reactivator, induces apoptosis and enhances chemotherapeutic cytotoxicity in pancreatic cancer cell lines |
| Q38994016 | Pharmacophore reassignment for induction of the immunosurveillance cytokine TRAIL. |
| Q35480734 | Regulating TRAIL receptor-induced cell death at the membrane : a deadly discussion |
| Q38034651 | Regulation of the human TRAIL gene. |
| Q35015253 | Sensitivity and dose dependency of radiation-induced injury in hematopoietic stem/progenitor cells in mice. |
| Q89498245 | Single-cell morphology encodes metastatic potential |
| Q54319356 | Sp1, acetylated histone-3 and p300 regulate TRAIL transcription: mechanisms of PDGF-BB-mediated VSMC proliferation and migration. |
| Q39175219 | Sparse multivariate factor analysis regression models and its applications to integrative genomics analysis |
| Q37785559 | TRAIL receptor signaling and therapeutics. |
| Q35149642 | The angular structure of ONC201, a TRAIL pathway-inducing compound, determines its potent anti-cancer activity |
| Q37687474 | The cell death machinery governed by the p53 tumor suppressor in response to DNA damage |
| Q33516218 | The combination of 5-fluorouracil plus p53 pathway restoration is associated with depletion of p53-deficient or mutant p53-expressing putative colon cancer stem cells |
| Q41809274 | The effects of graded levels of calorie restriction: VII. Topological rearrangement of hypothalamic aging networks |
| Q35878526 | The relative contribution of pro-apoptotic p53-target genes in the triggering of apoptosis following DNA damage in vitro and in vivo |
| Q35667591 | Transcriptional gene silencing of HIV-1 through promoter targeted RNA is highly specific |
| Q38074861 | Transcriptional regulation of tumour necrosis factor-related apoptosis-inducing ligand |
| Q52958210 | Transcriptomic analysis to elucidate the molecular mechanisms that underlie feed efficiency in meat-type chickens. |
| Q53193985 | Upregulated p53 expression activates apoptotic pathways in wild-type p53-bearing mesothelioma and enhances cytotoxicity of cisplatin and pemetrexed. |
| Q36951892 | Utilization of gene expression signature for quality control of traditional Chinese medicine formula Si-Wu-Tang |
| Q51761242 | p53 as a Dichotomous Regulator of Liver Disease: The Dose Makes the Medicine. |
| Q90225121 | p53-Mediated Oxidative Stress Enhances Indirubin-3'-Monoxime-Induced Apoptosis in HCT116 Colon Cancer Cells by Upregulating Death Receptor 5 and TNF-Related Apoptosis-Inducing Ligand Expression |
| Q34547830 | p53-Reactivating small molecules induce apoptosis and enhance chemotherapeutic cytotoxicity in head and neck squamous cell carcinoma |
| Q41715894 | p53: key conductor of all anti-acne therapies |
Search more.